Tea polyphenols improve the memory in aging ovariectomized rats by regulating brain glucose metabolism in vivo and in vitro

[1]  Luping Zhang,et al.  Tea polyphenols ameliorates memory decline in aging model rats by inhibiting brain TLR4/NF-κB inflammatory signaling pathway caused by intestinal flora dysbiosis , 2021, Experimental Gerontology.

[2]  R. Dong,et al.  Combination of tea polyphenols and proanthocyanidins prevents menopause-related memory decline in rats via increased hippocampal synaptic plasticity by inhibiting p38 MAPK and TNF-α pathway , 2021, Nutritional neuroscience.

[3]  H. Koepsell.  Glucose transporters in brain in health and disease , 2020, Pflügers Archiv - European Journal of Physiology.

[4]  B. Kuehn.  In Alzheimer Research, Glucose Metabolism Moves to Center Stage. , 2020, JAMA.

[5]  R. Kayed,et al.  Advances and considerations in AD tau-targeted immunotherapy , 2019, Neurobiology of Disease.

[6]  N. Weintraub,et al.  RNAase III-Type Enzyme Dicer Regulates Mitochondrial Fatty Acid Oxidative Metabolism in Cardiac Mesenchymal Stem Cells , 2019, International journal of molecular sciences.

[7]  A. Dey,et al.  In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition. , 2019, Clinical nuclear medicine.

[8]  Wenjie Luo,et al.  The complexity of tau in Alzheimer’s disease , 2019, Neuroscience Letters.

[9]  D. Butterfield,et al.  Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease , 2019, Nature Reviews Neuroscience.

[10]  H. Brody.  Tea , 2019, Nature.

[11]  Jiehui Jiang,et al.  Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images , 2019, Molecular imaging.

[12]  M. Farzaei,et al.  Role of green tea catechins in prevention of age‐related cognitive decline: Pharmacological targets and clinical perspective , 2018, Journal of cellular physiology.

[13]  S. Correia,et al.  O-GlcNAcylation and neuronal energy status: Implications for Alzheimer’s disease , 2018, Ageing Research Reviews.

[14]  A. Slomski.  Aβ-Clearing Drug Fails to Slow Alzheimer Disease. , 2018, Journal of the American Medical Association (JAMA).

[15]  K. Kantarci,et al.  Understanding the impact of sex and gender in Alzheimer's disease: A call to action , 2018, Alzheimer's & Dementia.

[16]  M. Beal,et al.  Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy , 2018, Human molecular genetics.

[17]  L. Ferrucci,et al.  Evidence for brain glucose dysregulation in Alzheimer's disease , 2018, Alzheimer's & Dementia.

[18]  N. Sang,et al.  Abnormal energy metabolism and tau phosphorylation in the brains of middle-aged mice in response to atmospheric PM2.5 exposure. , 2017, Journal of environmental sciences.

[19]  T. Dinan,et al.  Neurobehavioural effects of Lactobacillus rhamnosus GG alone and in combination with prebiotics polydextrose and galactooligosaccharide in male rats exposed to early-life stress , 2017, Nutritional neuroscience.

[20]  E. Mazzon,et al.  Role of Vitamin E in the Treatment of Alzheimer’s Disease: Evidence from Animal Models , 2017, International journal of molecular sciences.

[21]  M. Ismail,et al.  Edible Bird's Nest Prevents Menopause-Related Memory and Cognitive Decline in Rats via Increased Hippocampal Sirtuin-1 Expression , 2017, Oxidative medicine and cellular longevity.

[22]  W. Wu,et al.  Fructo-oligosaccharide improved brain β-amyloid, β-secretase, cognitive function, and plasma antioxidant levels in D-galactose-treated Balb/cJ mice , 2017, Nutritional neuroscience.

[23]  B. Su,et al.  Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases , 2017, Antioxidants.

[24]  A. Mendonça,et al.  Enhanced LTP in aged rats: Detrimental or compensatory? , 2017, Neuropharmacology.

[25]  C. Pike.  Sex and the development of Alzheimer's disease , 2017, Journal of neuroscience research.

[26]  M. Islam.  Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders , 2017, Neurological research.

[27]  L. Szablewski.  Glucose Transporters in Brain: In Health and in Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.

[28]  Ovais Shafi.  Inverse relationship between Alzheimer’s disease and cancer, and other factors contributing to Alzheimer’s disease: a systematic review , 2016, BMC Neurology.

[29]  A. Pines.  Alzheimer's disease, menopause and the impact of the estrogenic environment , 2016, Climacteric : the journal of the International Menopause Society.

[30]  C. Gonçalves,et al.  Intracerebroventricular administration of okadaic acid induces hippocampal glucose uptake dysfunction and tau phosphorylation , 2016, Brain Research Bulletin.

[31]  T. Gale,et al.  Sex differences in cognitive impairment in Alzheimer's disease. , 2016, World journal of psychiatry.

[32]  T. Cassano,et al.  Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease. , 2016, Pharmacological research.

[33]  L. Scorrano,et al.  Mito-Morphosis: Mitochondrial Fusion, Fission, and Cristae Remodeling as Key Mediators of Cellular Function. , 2016, Annual review of physiology.

[34]  E. Mandelkow,et al.  Tau in physiology and pathology , 2015, Nature Reviews Neuroscience.

[35]  H. Zhao,et al.  Resveratrol decreases the insoluble Aβ1–42 level in hippocampus and protects the integrity of the blood–brain barrier in AD rats , 2015, Neuroscience.

[36]  Maxwell I. Zimmerman,et al.  Antiparallel β-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-β Peptides When They Form 150-kDa Oligomers. , 2015, Journal of molecular biology.

[37]  J. Hanover,et al.  A little sugar goes a long way: The cell biology of O-GlcNAc , 2015, The Journal of cell biology.

[38]  Keith A. Johnson,et al.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging , 2015, Neuropathology and applied neurobiology.

[39]  D. Leprince,et al.  O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins , 2014, Front. Endocrinol..

[40]  Yuantao Li,et al.  Ketamine administered to pregnant rats in the second trimester causes long-lasting behavioral disorders in offspring , 2014, Neurobiology of Disease.

[41]  G. Tell,et al.  A short review on the implications of base excision repair pathway for neurons: relevance to neurodegenerative diseases. , 2014, Mitochondrion.

[42]  G. Han,et al.  Green tea polyphenols protect against okadaic acid-induced acute learning and memory impairments in rats. , 2014, Nutrition.

[43]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[44]  N. Mori,et al.  Fucoidan Therapy Decreases the Proviral Load in Patients with Human T-Lymphotropic Virus Type-1-Associated Neurological Disease , 2011, Antiviral therapy.

[45]  K. Ashe,et al.  Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.

[46]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[47]  Roberto Pastor-Barriuso,et al.  Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality , 2005, Annals of Internal Medicine.

[48]  Xiao-wei Ma,et al.  Antioxidative and Neuroprotective Effects of Curcumin in an Alzheimer's Disease Rat Model Co-Treated with Intracerebroventricular Streptozotocin and Subcutaneous D-Galactose. , 2016, Journal of Alzheimer's disease : JAD.

[49]  R. Shytle,et al.  Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction. , 2011, Journal of Alzheimer's disease : JAD.

[50]  S. Mandel,et al.  Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases. , 2011, Journal of Alzheimer's disease : JAD.

[51]  D. Butterfield,et al.  Vitamin E Prevents Alzheimer's Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production. , 2000, Journal of Alzheimer's disease : JAD.